Single-use Bioreactors Market: Growth, Size, Share, and Trends

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include World Health Organization (WHO), National Institutes of Health (NIH), United States Food and Drug Administration (US FDA), National Institute for Bioreactors Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), European Patent Office (EPO), Pharmaceuticals Export Promotion Council of India (Pharmexcil), India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, BioProcess International, Journal of Bioreactors and Biotechniques, BioPlan Associates, Eurostat, and Factiva, research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global single-use bioreactors market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biotechnology companies, CROs, CMOs, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the Asia Pacific, North America, Europe, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

• The key players in the industry and market have been identified through extensive secondary research
• The revenues generated from the single-use bioreactors business of leading players have been determined through primary and secondary research
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Single-use bioreactors (SUBs) or disposable bioreactors are vessels that consist of a disposable bag instead of a typical culture vessel made of stainless steel or glass. SUBs are based on single-use technology, which uses disposable equipment to manufacture biopharmaceutical products. The key benefits of single-use bioreactor include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater flexibility in manufacturing. These advantages make single-use systems particularly attractive for the production of biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.

Stakeholders

• Manufacturers of Single-use bioreactors and associated products
• Distributors of Single-use bioreactors and associated products
• Pharmaceutical and Biotechnology Companies
• Contract Manufacturing Companies (CMOs)
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Life Sciences Companies
• Market Research and Consulting Firms
• Venture Capitalists and Investors
• Government Organizations
• Medical Institutes and Universities
• Private Research Firms

Report Objectives

• To define, describe, and forecast the single use bioreactors market based on product, type, molecule type, cell type, application, end user, and region
• To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall single-use bioreactors market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market segments with respect to six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
• To profile the key players in the single use bioreactors market and comprehensively analyze their product portfolios, market positions, and core competencies
• To track and analyze competitive developments in the single use bioreactors market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
• To benchmark players within the single use bioreactors market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

1 Micro markets are the further segments and subsegments of the single use bioreactors market included in the report

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

• Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

• Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

• A further breakdown of the Rest of Asia Pacific single use bioreactors market into countries
• A further breakdown of the Rest of European single use bioreactors market into countries
• A further breakdown of the Rest of Latin American single use bioreactors market into countries
• A further breakdown of the Rest of Middle East single use bioreactors market into countries